SCHEMBL2293565

SCHEMBL2293565

CCOC(=O)c1cc(-c2ccc([N+](=O)[O-])c(C)c2)no1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.46
NPC1 O15118 4/20 0.46
GSTP1 P09211 2/20 0.45
GSTM2 P28161 2/20 0.45
ALDH1A1 P00352 5/20 0.45
MAPT P10636 4/20 0.41
GAA P10253 1/20 0.41
TSHR P16473 1/20 0.40
LMNA P02545 3/20 0.40
KMT2A Q03164 2/20 0.40
AR P10275 1/20 0.40
HTT P42858 1/20 0.39
PKM P14618 1/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 1/20 0.39
NFKB1 P19838 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2294502 0.89 GSTP1 (0.44) RAB9ANPC1GSTP1GSTM2ALDH1A1
SCHEMBL2296719 0.84 RAB9A (0.54) RAB9AMAPTGAALMNAKMT2A
SCHEMBL4699904 0.82 ERN1 (0.42) ALDH1A1MAPTGAALMNAHTT
SCHEMBL2297228 0.81 MAPT (0.62) RAB9ANPC1ALDH1A1MAPTKMT2A
SCHEMBL2297766 0.81 KDM4E (0.43) RAB9ANPC1ALDH1A1MAPTTSHR
SCHEMBL11509779 0.79 PPARG (0.48) RAB9ANPC1ALDH1A1MAPTSMN1; SMN2
SCHEMBL11972313 0.77 CA12 (0.53) RAB9AALDH1A1MAPTLMNAHTT
SCHEMBL12126125 0.77 HTT (0.39) RAB9ANPC1ALDH1A1MAPTHTT
SCHEMBL2294258 0.76 LMNA (0.54) RAB9ANPC1ALDH1A1MAPTGAA
SCHEMBL2180427 0.76 SMN1; SMN2 (0.58) RAB9ANPC1ALDH1A1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835428-B2 Diacylglycerol acyltransferase inhibitors Piramal Enterprises Limited (IN) 2014-09-16 US disclosed
US-20110196002-A1 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS PIRAMAL LIFE SCIENCES LIMITED. 2011-08-11 US disclosed
WO-2010023609-A1 OXAZOLE, OXADIAZOLE AND THIAZOLE DERIVATIVES AS DIACYLGLYCEROL ACYLTRANFERASE INHIBITORS PIRAMAL LIFE SCIENCES LIMITED (IN) 2010-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110196002-A1 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS DGAT1, DGAT2, DLAT RAB9A 3753/4885NPC1 436/4885GSTP1 1185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.